Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9625)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2015 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Kadowaki S, Kakuta M, Takahashi S, Takahashi A, Arai Y, Nishimura Y, Yatsuoka T, Ooki A, Yamaguchi K, Matsuo K, Muro K, Akagi K. Prognostic value of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i4/1275.htm |
| Number | Citing Articles |
| 1 |
Angelika Svetlove, Titus Griebel, Jonas Albers, Lorenzo D’Amico, Philipp Nolte, Giuliana Tromba, Hanibal Bohnenberger, Frauke Alves, Christian Dullin. X-ray phase-contrast 3D virtual histology characterises complex tissue architecture in colorectal cancer. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1283052
|
| 2 |
M. Gil-Raga, E. Jantus-Lewintre, S. Gallach, V. Giner-Bosch, A. Frangi-Caregnato, M. J. Safont-Aguilera, J. Garde-Noguera, E. Zorraquino-Pina, M. García-Martínez, C. Camps-Herrero. Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis. Clinical and Translational Oncology 2018; 20(11): 1422 doi: 10.1007/s12094-018-1874-8
|
| 3 |
Federica Tosi, Elena Magni, Alessio Amatu, Gianluca Mauri, Katia Bencardino, Mauro Truini, Silvio Veronese, Luciano De Carlis, Giovanni Ferrari, Michele Nichelatti, Andrea Sartore-Bianchi, Salvatore Siena. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis. Clinical Colorectal Cancer 2017; 16(3): e153 doi: 10.1016/j.clcc.2017.01.004
|
| 4 |
Rajesh Kumar, Seetha Harilal, Simone Carradori, Bijo Mathew. A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century. Current Medicinal Chemistry 2021; 28(14): 2657 doi: 10.2174/0929867327666201026143757
|
| 5 |
Takuma Iwai, Takeshi Yamada, Hiromichi Sonoda, Akihisa Matsuda, Seiichi Shinji, Kohki Takeda, Koji Ueda, Sho Kuriyama, Toshimitsu Miyasaka, Hiroshi Yoshida. Utility of Cell-free DNA in the Treatment of <i>BRAF</i> V600E Mutation-positive Colorectal Cancer. Nippon Daicho Komonbyo Gakkai Zasshi 2023; 76(2): 123 doi: 10.3862/jcoloproctology.76.123
|
| 6 |
Nazli Kunt, Murat Araz, Mahmut Selman Yildirim, Siddika Findik, Mehmet Zahid Kocak, Melek Karakurt Eryilmaz, Mehmet Artac. The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers. Journal of Gastrointestinal Cancer 2023; 54(4): 1316 doi: 10.1007/s12029-023-00943-2
|
| 7 |
Van Morris, Wei Qiao, Scott Kopetz. BRAF Mutations in Non-Metastatic Colorectal Cancer: Current Relevance and Future Implications. Current Colorectal Cancer Reports 2015; 11(6): 303 doi: 10.1007/s11888-015-0295-0
|
| 8 |
Asad Ali, Juber Akhtar, Usama Ahmad, Abdul Samad Basheer, Neha Jaiswal, Afroz Jahan.
Armamentarium in Drug Delivery for Colorectal Cancer
. Critical Reviews™ in Therapeutic Drug Carrier Systems 2023; 40(1): 1 doi: 10.1615/CritRevTherDrugCarrierSyst.2022039241
|
| 9 |
Johan Gagnière, Aurélien Dupré, Sepideh S. Gholami, Denis Pezet, Thomas Boerner, Mithat Gönen, Thomas P. Kingham, Peter J. Allen, Vinod P. Balachandran, Ronald P. De Matteo, Jeffrey A. Drebin, Rona Yaeger, Nancy E. Kemeny, William R. Jarnagin, Michael I. D’Angelica. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?. Annals of Surgery 2020; 271(1): 147 doi: 10.1097/SLA.0000000000002968
|
| 10 |
Ana Paula Simedan Vila, Gabriela Helena Rodrigues, Ludmila Leite Marzochi, Juliana Garcia de Oliveira-Cucolo, Ana Lívia Silva Galbiatti-Dias, Rafael Felipe Maciel Andrade, Dalísio de Santi Neto, João Gomes Netinho, Lilian Castiglioni, Érika Cristina Pavarino, Eny Maria Goloni-Bertollo. Epidemiological and molecular evaluation of BRAF, KRAS, NRAS genes and MSI in the development of colorectal cancer. Gene 2023; 870: 147395 doi: 10.1016/j.gene.2023.147395
|
| 11 |
Kiyoko Takane, Kiwamu Akagi, Masaki Fukuyo, Koichi Yagi, Tadatoshi Takayama, Atsushi Kaneda. DNA methylation epigenotype and clinical features of NRAS‐mutation(+) colorectal cancer. Cancer Medicine 2017; 6(5): 1023 doi: 10.1002/cam4.1061
|
| 12 |
Yajun Yu, Megan Carey, William Pollett, Jane Green, Elizabeth Dicks, Patrick Parfrey, Yildiz E. Yilmaz, Sevtap Savas. The long-term survival characteristics of a cohort of colorectal cancer patients and baseline variables associated with survival outcomes with or without time-varying effects. BMC Medicine 2019; 17(1) doi: 10.1186/s12916-019-1379-5
|
| 13 |
Tetsuya Ito, Koji Kono, Hidetaka Eguchi, Yasushi Okazaki, Gou Yamamoto, Tetsuhiko Tachikawa, Kiwamu Akagi, Yohei Okada, Satoru Kawakami, Makoto Morozumi, Jun-ichi Tamaru, Hideyuki Ishida. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population. Japanese Journal of Clinical Oncology 2020; 50(1): 80 doi: 10.1093/jjco/hyz140
|
| 14 |
Ozgur Kirbiyik, Berk Özyilmaz. Colon Polyps and Colorectal Cancer. 2021; : 481 doi: 10.1007/978-3-030-57273-0_24
|
| 15 |
Hande Beklen, Esra Yildirim, Medi Kori, Beste Turanli, Kazim Yalcin Arga. Systems-level biomarkers identification and drug repositioning in colorectal cancer. World Journal of Gastrointestinal Oncology 2021; 13(7): 463 doi: 10.4251/wjgo.v13.i7.463
|
| 16 |
Moritz Jesinghaus, Björn Konukiewitz, Gisela Keller, Matthias Kloor, Katja Steiger, Magdalena Reiche, Roland Penzel, Volker Endris, Ruza Arsenic, Gratiana Hermann, Albrecht Stenzinger, Wilko Weichert, Nicole Pfarr, Günter Klöppel. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Modern Pathology 2017; 30(4): 610 doi: 10.1038/modpathol.2016.220
|
| 17 |
Alissa Greenbaum, Charles Wiggins, Angela LW Meisner, Manuel Rojo, Anita Y Kinney, Ashwani Rajput. KRAS biomarker testing disparities in colorectal cancer patients in New Mexico. Heliyon 2017; 3(11): e00448 doi: 10.1016/j.heliyon.2017.e00448
|
| 18 |
Ehsan Nazemalhosseini-Mojarad, Roya Kishani Farahani, Maryam Mehrizi, Kaveh Baghaei, Mohammad Yaghoob Taleghani, Mina Golmohammadi, Noshad Peyravian, Sara Ashtari, Mohmad Amin Pourhoseingholi, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability. Journal of Gastrointestinal Cancer 2020; 51(1): 53 doi: 10.1007/s12029-019-00201-4
|
| 19 |
Daeyoun David Won, Jae Im Lee, In Kyu Lee, Seong-Taek Oh, Eun Sun Jung, Sung Hak Lee. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3381-7
|
| 20 |
Xiangyan Zhang, Jie Wu, Lili Wang, Han Zhao, Hong Li, Yuhe Duan, Yujun Li, Ping Xu, Wenwen Ran, Xiaoming Xing. HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China. PeerJ 2020; 8: e8602 doi: 10.7717/peerj.8602
|
| 21 |
Hye Lee, Dae Hwang, Hye Han. Histology and its prognostic effect on KRAS‑mutated colorectal carcinomas in Korea. Oncology Letters 2020; 20(1): 655 doi: 10.3892/ol.2020.11606
|
| 22 |
Marco Tonello, Dario Baratti, Paolo Sammartino, Andrea Di Giorgio, Manuela Robella, Cinzia Sassaroli, Massimo Framarini, Mario Valle, Antonio Macrì, Luigina Graziosi, Federico Coccolini, Piero Vincenzo Lippolis, Roberta Gelmini, Marcello Deraco, Daniele Biacchi, Francesco Santullo, Marco Vaira, Katia Di Lauro, Fabrizio D’Acapito, Fabio Carboni, Giuseppe Giuffrè, Annibale Donini, Paola Fugazzola, Pinuccia Faviana, Lorena Sorrentino, Antonio Scapinello, Paola Del Bianco, Antonio Sommariva. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Annals of Surgical Oncology 2022; 29(6): 3405 doi: 10.1245/s10434-021-11045-3
|
| 23 |
Paweł M. Potocki, Piotr Wójcik, Łukasz Chmura, Bartłomiej Goc, Marcin Fedewicz, Zofia Bielańska, Jakub Swadźba, Kamil Konopka, Łukasz Kwinta, Piotr J. Wysocki. Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study. International Journal of Molecular Sciences 2023; 24(10): 9073 doi: 10.3390/ijms24109073
|
| 24 |
Laurence Gau, Mathieu Ribeiro, Bruno Pereira, Karine Poirot, Aurélien Dupré, Denis Pezet, Johan Gagnière. Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis. European Journal of Surgical Oncology 2021; 47(11): 2722 doi: 10.1016/j.ejso.2021.05.039
|
| 25 |
Mehmet Ali Gültekin, Hacı Mehmet Türk, Mehmet Beşiroğlu, Hüseyin Toprak, Ismail Yurtsever, Temel Fatih Yilmaz, Rasul Sharifov, Ömer Uysal. Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study. European Journal of Radiology 2020; 125: 108895 doi: 10.1016/j.ejrad.2020.108895
|
| 26 |
Anita Sveen, Scott Kopetz, Ragnhild A. Lothe. Biomarker-guided therapy for colorectal cancer: strength in complexity. Nature Reviews Clinical Oncology 2020; 17(1): 11 doi: 10.1038/s41571-019-0241-1
|
| 27 |
Kai Xu, Jiayuan Wang, Jing Gao, Jiabo Di, Beihai Jiang, Lei Chen, Zaozao Wang, Aidong Wang, Fan Wu, Wei Wu, Lin Shen, Xiangqian Su. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer. Oncology Reports 2016; 36(3): 1672 doi: 10.3892/or.2016.4961
|
| 28 |
Jun Li, Aihua Sun, Guofang Zhong, Ying He, Hailin Xiong, Xia Yuan. Mutation analysis of a 10-gene panel for colorectal cancer in Huizhou, Guangdong Province of China. Journal of International Medical Research 2021; 49(11) doi: 10.1177/03000605211061040
|
| 29 |
Elham Serki, Atena Mansouri, Mohammad Malekaneh, Mohsen Naseri. Evaluation of BRAF Mutations in Patients with Colorectal Cancer in
the East of Iran. Current Pharmacogenomics and Personalized Medicine 2023; 20(2): 87 doi: 10.2174/1875692120666230602115139
|
| 30 |
Andrea Sartore-Bianchi, Alessio Amatu, Erica Bonazzina, Stefano Stabile, Laura Giannetta, Giulio Cerea, Ilaria Schiavetto, Katia Bencardino, Chiara Funaioli, Riccardo Ricotta, Tiziana Cipani, Michele Schirru, Valentina Gambi, Laura Palmeri, Giulia Carlo-Stella, Francesca Rusconi, Sara Di Bella, Giovanni Burrafato, Andrea Cassingena, Emanuele Valtorta, Calogero Lauricella, Federica Pazzi, Alessandra Gambaro, Silvia Ghezzi, Giovanna Marrapese, Emiliana Tarenzi, Silvio Veronese, Mauro Truini, Angelo Vanzulli, Salvatore Siena. Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience. Targeted Oncology 2017; 12(4): 525 doi: 10.1007/s11523-017-0505-6
|
| 31 |
Mahmood Moosazadeh, Azita sadough, Mahdi Afshari, Saeed barzegari, Ghasem Janbabaee, Reza Tabrizi, Maryam Akbari, Reza Alizadeh‐Navaei, Akbar Hedayatizadeh‐Omran, Fereshteh Rostami-Maskopaee. Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta‐analysis. European Journal of Cancer Care 2019; 28(6) doi: 10.1111/ecc.13160
|
| 32 |
Yash Pershad, Siddharth Govindan, Amy Hara, Mitesh Borad, Tanios Bekaii-Saab, Alex Wallace, Hassan Albadawi, Rahmi Oklu. Using Naïve Bayesian Analysis to Determine Imaging Characteristics of KRAS Mutations in Metastatic Colon Cancer. Diagnostics 2017; 7(3): 50 doi: 10.3390/diagnostics7030050
|
| 33 |
Ke-Min Jin, Kun Wang, Quan Bao, Hong-Wei Wang, Bao-Cai Xing. Liver resection for colorectal liver-limited metastases in elderly patients: a propensity score matching analysis. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02055-8
|
| 34 |
Jianhua Liu, Weiqiang Zeng, Chengzhi Huang, Junjiang Wang, Dongyang Yang, Dong Ma. Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/4585802
|
| 35 |
Xiang-Bin Wan, Ai-Qin Wang, Jian Cao, Zhi-Chuang Dong, Ning Li, Sen Yang, Miao-Miao Sun, Zhi Li, Su-Xia Luo. Relationships among <i>KRAS</i> mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer. World Journal of Gastroenterology 2019; 25(7): 808-823 doi: 10.3748/wjg.v25.i7.808
|
| 36 |
Yanyan Xu, Qiaoyu Xu, Hongliang Sun, Tongxi Liu, Kaining Shi, Wu Wang. Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?. European Radiology 2018; 28(7): 3059 doi: 10.1007/s00330-018-5329-y
|
| 37 |
Kenji Fujiyoshi, Tatsuro Yamaguchi, Miho Kakuta, Akemi Takahashi, Yoshiko Arai, Mina Yamada, Gou Yamamoto, Sachiko Ohde, Misato Takao, Shin‐ichiro Horiguchi, Soichiro Natsume, Shinsuke Kazama, Yusuke Nishizawa, Yoji Nishimura, Yoshito Akagi, Hirohiko Sakamoto, Kiwamu Akagi. Predictive model for high‐frequency microsatellite instability in colorectal cancer patients over 50 years of age. Cancer Medicine 2017; 6(6): 1255 doi: 10.1002/cam4.1088
|
| 38 |
Ehsan Gharib, Gilles A. Robichaud. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies. International Journal of Molecular Sciences 2024; 25(17): 9463 doi: 10.3390/ijms25179463
|
| 39 |
Tomohiro Sugiyama, Moriya Iwaizumi, Masanao Kaneko, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Takahisa Furuta, Hiroaki Miyajima, Satoshi Osawa, Satoshi Baba, Masato Maekawa, Ken Sugimoto. DNA mismatch repair is not disrupted in stage 0 colorectal cancer resected using endoscopic submucosal dissection. Oncology Letters 2020; 20(3): 2435 doi: 10.3892/ol.2020.11799
|
| 40 |
Aghigh koochak, Nasser Rakhshani, Mohammad Hadi Karbalaie Niya, Fahimeh Safarnezhad Tameshkel, Masoud Reza Sohrabi, Mohammad Reza Babaee, Hamid Rezvani, Babak Bahar, Farid Imanzade, Farhad Zamani, Mohammad Reza Khonsari, Hossein Ajdarkosh, Gholamreza Hemmasi. Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran. Asian Pacific Journal of Cancer Prevention 2016; 17(2): 603 doi: 10.7314/APJCP.2016.17.2.603
|
| 41 |
Lili Duan, Wanli Yang, Xiaoqian Wang, Wei Zhou, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Advances in prognostic markers for colorectal cancer. Expert Review of Molecular Diagnostics 2019; 19(4): 313 doi: 10.1080/14737159.2019.1592679
|
| 42 |
Hande Beklen, Esra Yildirim, Medi Kori, Beste Turanli, Kazim Yalcin Arga. Systems-level biomarkers identification and drug repositioning in colorectal cancer. World Journal of Gastrointestinal Oncology 2021; 13(7): 638-661 doi: 10.4251/wjgo.v13.i7.638
|
| 43 |
Jia Liu, Biao Wang, Wentong Fang. Microsatellite instability and sensitivity to fluoropyrimidine and oxaliplatin containing first-line chemotherapy in metastatic colorectal cancer. European Journal of Hospital Pharmacy 2020; 27(5): 267 doi: 10.1136/ejhpharm-2018-001657
|
| 44 |
Sakura Hiraide, Masanobu Takahashi, Yuya Yoshida, Hideharu Yamada, Keigo Komine, Chikashi Ishioka. Tumor suppressor miR‐193a‐3p enhances efficacy of BRAF/MEK inhibitors in BRAF‐mutated colorectal cancer. Cancer Science 2021; 112(9): 3856 doi: 10.1111/cas.15075
|
| 45 |
Chia Yuen Chong, Azim Jalali, Hui Li Wong, Matthew Loft, Rachel Wong, Margaret Lee, Lucy Gately, Wei Hong, Jeremy Shapiro, Suzanne Kosmider, Jeannie Tie, Sumitra Ananda, Justin M Yeung, Brigette Ma, Matthew Burge, Ross Jennens, Ben Tran, Belinda Lee, Lionel Lim, Andrew Dean, Louise Nott, Peter Gibbs. Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology 2022; 18(5) doi: 10.1111/ajco.13728
|
| 46 |
Keigo Matsunaga, Kazuhito Sasaki, Keisuke Hata, Hiroaki Nozawa, Kazushige Kawai, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Hirofumi Sonoda, Koji Ueda, Sho Kuriyama, Takeshi Yamada, Hiroshi Yoshida, Soichiro Ishihara. Clinical significance of the KRAS G13D mutation in anastomotic recurrence of colorectal cancer. Oncology Letters 2023; 25(5) doi: 10.3892/ol.2023.13778
|
| 47 |
Emma O’Riordan, Michael William Bennett, Louise Daly, Derek G Power. The implication of BRAF mutation in advanced colorectal cancer. Irish Journal of Medical Science (1971 -) 2022; 191(6): 2467 doi: 10.1007/s11845-021-02689-x
|
| 48 |
Ghazaleh Khalili-Tanha, Reza Mohit, Alireza Asadnia, Majid Khazaei, Mohammad Dashtiahangar, Mina Maftooh, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Mohammad Ali Kiani, Gordon A. Ferns, Jyotsna Batra, Elham Nazari, Amir Avan. Identification of ZMYND19 as a novel biomarker of colorectal cancer: RNA-sequencing and machine learning analysis. Journal of Cell Communication and Signaling 2023; 17(4): 1469 doi: 10.1007/s12079-023-00779-2
|
| 49 |
Carsten Kamphues, Shigenori Kadowaki, Neda Amini, Inge van den Berg, Jaeyun Wang, Nikolaos Andreatos, Yuki Sakamoto, Toshiro Ogura, Miho Kakuta, Anastasia Pikouli, Despoina Geka, Nobuya Daitoku, Maria Theochari, Stefan Buettner, Takahiko Akiyama, Efstathios Antoniou, Emmanouil Pikoulis, George Theodoropoulos, Katsunori Imai, Jan N. M. Ijzermans, Georgios A. Margonis, Kiwamu Akagi, Martin E. Kreis. The interplay of KRAS mutational status with tumor laterality in non‐metastatic colorectal cancer: An international, multi‐institutional study in patients with known KRAS, BRAF, and MSI status. Journal of Surgical Oncology 2021; 123(4): 1005 doi: 10.1002/jso.26352
|
| 50 |
Grazia Palomba, Valentina Doneddu, Antonio Cossu, Panagiotis Paliogiannis, Antonella Manca, Milena Casula, Maria Colombino, Annamaria Lanzillo, Efisio Defraia, Antonio Pazzola, Giovanni Sanna, Carlo Putzu, Salvatore Ortu, Mario Scartozzi, Maria Teresa Ionta, Giovanni Baldino, Giuseppina Sarobba, Francesca Capelli, Tito Sedda, Luciano Virdis, Michela Barca, Giulia Gramignano, Mario Budroni, Francesco Tanda, Giuseppe Palmieri. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1053-z
|
| 51 |
Kenji Fujiyoshi, Gou Yamamoto, Akemi Takahashi, Yoshiko Arai, Mina Yamada, Miho Kakuta, Kensei Yamaguchi, Yoshito Akagi, Yoji Nishimura, Hirohiko Sakamoto, Kiwamu Akagi. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. Oncology Reports 2017; 37(2): 785 doi: 10.3892/or.2016.5323
|
| 52 |
Inés Mármol, Cristina Sánchez-de-Diego, Alberto Pradilla Dieste, Elena Cerrada, María Rodriguez Yoldi. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(1): 197 doi: 10.3390/ijms18010197
|
| 53 |
Anastasios Ntavatzikos, Aris Spathis, Paul Patapis, Nikolaos Machairas, Georgia Vourli, George Peros, Iordanis Papadopoulos, Ioannis Panayiotides, Anna Koumarianou. TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer. World Journal of Gastrointestinal Oncology 2019; 11(7): 551-566 doi: 10.4251/wjgo.v11.i7.551
|
| 54 |
Kayoko Nakano, Hidetaka Yamamoto, Minako Fujiwara, Yutaka Koga, Shinichi Tsuruta, Eikichi Ihara, Eiji Oki, Masafumi Nakamura, Yoshihiro Ogawa, Yoshinao Oda. Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency. American Journal of Surgical Pathology 2018; 42(2): 172 doi: 10.1097/PAS.0000000000000947
|
| 55 |
Donatella Verbanac, Andrea Čeri, Iva Hlapčić, Mehdi Shakibaei, Aranka Brockmueller, Božo Krušlin, Neven Ljubičić, Neven Baršić, Dijana Detel, Lara Batičić, Lada Rumora, Anita Somborac-Bačura, Mario Štefanović, Ivana Ćelap, Alma Demirović, Roberta Petlevski, József Petrik, Marija Grdić Rajković, Andrea Hulina-Tomašković, Ivana Rako, Luciano Saso, Karmela Barišić. Profiling Colorectal Cancer in the Landscape Personalized Testing—Advantages of Liquid Biopsy. International Journal of Molecular Sciences 2021; 22(9): 4327 doi: 10.3390/ijms22094327
|
| 56 |
Elena Orlandi, Mario Giuffrida, Serena Trubini, Enrico Luzietti, Massimo Ambroggi, Elisa Anselmi, Patrizio Capelli, Andrea Romboli. Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review. Diagnostics 2024; 14(10): 1001 doi: 10.3390/diagnostics14101001
|
| 57 |
Xiangyan Zhang, Wenwen Ran, Jie Wu, Hong Li, Huamin Liu, Lili Wang, Yujing Xiao, Xiaonan Wang, Yujun Li, Xiaoming Xing. Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China. PeerJ 2018; 6: e4341 doi: 10.7717/peerj.4341
|
| 58 |
Hiroya Taniguchi, Wataru Okamoto, Kei Muro, Kiwamu Akagi, Hiroki Hara, Tomohiro Nishina, Takeshi Kajiwara, Tadamichi Denda, Shuichi Hironaka, Toshihiro Kudo, Taroh Satoh, Takeharu Yamanaka, Yukiko Abe, Yoshiyuki Fukushima, Takayuki Yoshino. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study. Neoplasia 2018; 20(12): 1219 doi: 10.1016/j.neo.2018.10.004
|
| 59 |
Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. Oncotarget 2017; 8(50): 87837 doi: 10.18632/oncotarget.21237
|